Wellness
August 27, 2026·5 min read
If you started a medically supervised weight management program earlier this year, you're probably several months in now — and you may be wondering why the results feel uneven. The medication is doing something. But you sense there's more you could be doing. You're right. Semaglutide diet and exercise habits are not optional add-ons to a GLP-1 program — they're the variables that determine how much of that pharmacological signal actually translates into lasting change.
GLP-1 receptor agonists work in part by mimicking a gut hormone your body already makes. They slow gastric emptying, reduce appetite signaling in the brain, and improve insulin sensitivity. Tirzepatide adds a second receptor mechanism on top of GLP-1 — it activates GIP receptors as well. Both are real metabolic tools, and research published in peer-reviewed journals has helped clarify how they work at the physiological level.
But here's what the medication cannot do: it cannot tell your body where to pull energy from when you're in a calorie deficit. Without adequate protein intake and resistance training, a meaningful portion of weight lost can come from lean muscle mass — not just fat. And muscle is metabolically active tissue. Losing it makes long-term weight maintenance harder, not easier.
This is why I tell clients from the first visit: the medication quiets the noise so you can actually hear your body again. What you do with that quiet is what matters.
Compounded medication disclosure: The semaglutide and tirzepatide preparations dispensed by Enhance Aesthetics & Wellness are 503A compounded preparations, not FDA-approved finished pharmaceutical products. They are not the same as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®. The FDA approvals held by Novo Nordisk's branded semaglutide products and Eli Lilly's branded tirzepatide products do not transfer to compounded versions. Efficacy and safety data published in clinical trials of those branded products may not apply directly to compounded preparations.
The clients I see making the most meaningful progress in our medical weight management programs share a few consistent habits. Not perfection — consistency.
Protein first, every meal. When appetite is suppressed, it's easy to eat less of everything — including the protein your body needs to preserve muscle. The CDC's nutrition guidance and most clinical frameworks for weight management emphasize adequate protein as a non-negotiable foundation. A rough target for most adults is 0.7 to 1 gram of protein per pound of lean body mass, though this should be individualized at consultation.
Resistance training, not just cardio. Cardiovascular exercise is valuable — especially in a Yuma summer when early morning walks are about the only outdoor option that doesn't flatten you. But resistance training — two to three sessions per week — is what signals your body to hold onto muscle while losing fat. It doesn't have to be a gym. Bodyweight movements, resistance bands, and free weights at home all count.
Sleep as a metabolic variable. This one gets underestimated. Sleep deprivation elevates cortisol and disrupts the same appetite-regulating hormones the medication is working to modulate. Seven to nine hours is not a luxury; it's part of the protocol.
Stress management — not as an afterthought. Chronic stress keeps cortisol elevated, and elevated cortisol directly disrupts the metabolic improvements you're working toward. When cortisol stays high, it can promote fat storage — particularly visceral fat — and undermine the appetite regulation GLP-1s support. Stress reduction strategies are not soft add-ons. They're part of the clinical picture.
Individual results vary: Weight-loss outcomes depend on individualized factors including dose, duration, baseline weight, metabolic health, and lifestyle. Average weight-loss percentages reported in trials of branded products are not a guarantee of individual outcomes on compounded preparations or any specific protocol at Enhance Aesthetics & Wellness.
This is Yuma-specific advice. GLP-1 receptor agonists can cause gastrointestinal side effects — nausea and constipation are among the most common — and dehydration makes both significantly worse. In a climate where you can lose meaningful fluid volume before you've worked up a visible sweat, intentional hydration becomes part of your weight loss program lifestyle, not an afterthought.
Aim for at least half your body weight in ounces of water daily, more on high-heat days or if you're exercising. Electrolytes — particularly sodium, potassium, and magnesium — matter as much as fluid volume, especially if nausea has reduced your food intake. If you're struggling with GI symptoms and hydration feels difficult, that's worth a conversation at your next check-in.
You can also explore more about what we offer for hydration and overall wellness support on our health and wellness services page.
If your progress has slowed, the most common explanation is not that the medication stopped working. It's one of three things: dose timing and titration, protein and calorie intake creeping lower than is optimal, or sleep and stress variables that have worsened.
A plateau is information. It's usually not a sign to abandon the plan — it's a sign to look more carefully at the lifestyle inputs that sit alongside the medication. Mayo Clinic's guidance on healthy weight maintenance reinforces this framing: sustainable weight management involves ongoing adjustment, not a set-and-forget approach.
I also want to name what sometimes happens at month four or five: the novelty of the appetite suppression fades a little as your body adapts. That's normal. What matters at that point is whether the behavioral scaffolding — the protein habits, the movement, the sleep — is in place. The medication gave you a window. The scaffolding is what holds the window open.
Risks and contraindications: GLP-1 receptor agonists carry known risks including nausea, vomiting, constipation, gallbladder disease, and pancreatitis. Less commonly: hypoglycemia (especially in clients on diabetes medications), severe gastrointestinal complications, and rare allergic reactions. The labeled boxed warning for the branded products warns of risk of thyroid C-cell tumors; clients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take these medications. Pregnant and breastfeeding clients are not candidates.
Our weight loss injections and programs are structured around the idea that compounded GLP-1 therapy is one tool within a broader plan — not a standalone solution. At the initial consultation, Marina performs a medical screening, reviews labs, and discusses contraindications before any prescription is written. Dose titration, side effect management, and lifestyle reinforcement are part of every follow-up visit, not an afterthought.
If you're already in a program and feel like the lifestyle piece needs more attention, that's a completely valid thing to bring to your next appointment. If you're considering starting and wondering what the process looks like, the first conversation is exactly that — a conversation. No pressure to commit to anything beyond showing up.
If you'd like to talk through what's right for you, schedule a consultation at Enhance Aesthetics & Wellness. You can reach us at 928.370.4480.
Information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Individual results vary; outcomes shown or described are not guaranteed. Compounded medications referenced (including GLP-1 receptor agonists) are prepared by licensed compounding pharmacies under 503A patient-specific prescriptions and are not FDA-approved finished pharmaceutical products. Consult an Enhance clinician for guidance specific to your situation. Images may contain models. © 2026 Enhance Aesthetics & Wellness.
Medically reviewed by Marina Roloff, DNP, FNP-C — 2026-08-27
Schedule a Consultation
Marina Roloff, DNP, FNP-C — Enhance Aesthetics & Wellness, Yuma, AZ
CONTACT US